Evaluation of the leukocyte esterase test (LET) as pre-screening test to reduce costs for national population-based Chlamydia trachomatis screening programs

J Adolesc Health. 2006 Apr;38(4):332-3; author reply 333-4. doi: 10.1016/j.jadohealth.2005.11.004.

Authors

Servaas A Morré, Joke Spaargaren, Irene K Veldhuijzen, Maarten J Postma, Jan E A M van Bergen, J E A M van Bergen, J Broer, A J J Coenen, H M Götz, F de Groot, C J P A Hoebe, J H Richardus, D T van Schaik, I K Veldhuijzen, M Verhooren; PILOT CT study-group

PMID: 16549289
DOI: 10.1016/j.jadohealth.2005.11.004

No abstract available

Publication types

Comment
Letter

MeSH terms

Biological Assay / economics
Biological Assay / methods
Carboxylic Ester Hydrolases / analysis*
Chlamydia Infections / diagnosis*
Chlamydia Infections / economics
Chlamydia trachomatis / pathogenicity
Cost Control
DNA, Bacterial / analysis
Female
Humans
Male
Mass Screening / economics*
Mass Screening / methods
Polymerase Chain Reaction

Substances

DNA, Bacterial
leukocyte esterase
Carboxylic Ester Hydrolases